David Shaha, MD
Sleep Medicine · Eugene, ORNPI 1679912778
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $989 of the $1,375 with a category attached, or 71.9%. 9 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 48.2% of the total. 2025 is the largest year on record at $853, more than ten times the $63 reported in 2023.
Across 47 payments — averaging $29.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$663
- Harmony Biosciences LLC$200
- Avadel CNS Pharmaceuticals, LLC$160
- Axsome Therapeutics, Inc.$122
- Inspire Medical Systems, Inc.$91
- Resmed Corp$67
- plus $72 from 3 others
What the payments were for
- Consulting fees$15011%
- Food & beverage$98972%
- Education$23617%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 17 | $663 |
| Harmony Biosciences LLC | 10 | $200 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $160 |
| Axsome Therapeutics, Inc. | 6 | $122 |
| Inspire Medical Systems, Inc. | 3 | $91 |
| Resmed Corp | 2 | $67 |
| Philips North America LLC | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Fisher & Paykel Healthcare Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,375 in reported general payments places this provider in the 85th percentile of 36 sleep medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 16 | $970 |
| Gabapentin | 58 | $858 |
| Doxepin Hcl | 23 | $395 |
| Methadone Hcl | 16 | $317 |
| Ropinirole Hcl | 27 | $301 |
| Pregabalin | 13 | $241 |
| Prazosin Hcl | 11 | $240 |
| Clonazepam | 13 | $192 |
| Fluticasone Propionate | 12 | $145 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Eugene
- Radhika BreadenPortland$55K
- Anas RihawiPortland$5K
- Asha SinghBend$4K
- Jennifer KimPortland$2K
- Natalia UsatiiBend$1K
- Daniel RootPortland$1K
- Bradley DekorteMedford$1K
- David PanossianKlamath Falls$822
- Jonathan BrewerBend$757
- Vivek DograPortland$729
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.